The frontiers of cardiomyopathy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000686:Amyloidosis / Q000175:diagnosis; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D009202:Cardiomyopathies / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D002395:Catecholamines / Q000502:physiology; D003645:Death, Sudden / Q000209:etiology; D003937:Diagnosis, Differential; D003971:Diastole; D004719:Endomyocardial Fibrosis / Q000628:therapy; D006333:Heart Failure / Q000628:therapy; D006801:Humans
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines